San Diego—Can intraoperative dexamethasone have beneficial effects in patients undergoing cancer surgery? The answer appears to be yes, according to the results of a new study.
The investigation found that administration of the antiemetic agent was associated with lower 90-day mortality in patients undergoing cancer surgery, particularly those with nonimmunogenic forms of the disease. Nevertheless, a prominent anesthesiologist urged caution when interpreting the results.
“There are